XML 49 R35.htm IDEA: XBRL DOCUMENT v3.19.1
Note 1 - Significant Accounting Policies and Concentrations of Risk - Summary of Revenues (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Revenues $ 2,729 $ 1,454 $ 12,494 $ 3,976 $ 3,890 $ 8,760 $ 3,099 $ 9,437 $ 20,653 $ 25,186 $ 26,353
Product [Member]                      
Revenues                 1,501 2,269
Royalty [Member]                      
Revenues                 6,101 10,543 9,682
Collaborative and Other Research and Development [Member]                      
Revenues                 14,552 13,142 14,402
Collaborative and Other Research and Development [Member] | US Department of Health and Human Services [Member]                      
Revenues                 2,552 4,608 12,449
Collaborative and Other Research and Development [Member] | Shionogi and Co. Ltd [Member]                      
Revenues                 1,184 1,184
Collaborative and Other Research and Development [Member] | Seqirus UK Limited [Member]                      
Revenues                 $ 12,000 $ 7,350 $ 769